Podcasts about professor peter openshaw

As the emotional roller coaster of the Euros comes to a close and the summer Olympics begin, James joins Professor Damian Bailey for an experiment to measure the ups and downs of watching sport. We monitor brains, hearts, lungs and hormones to try to out if watching sport is good or bad for us. But is there an additional risk for sports fans attending the summer Olympics in Paris? As climate change drives the tiger mosquito northwards there are concerns over the potential spread of Dengue in France's capital. James talks to disease ecologist Dr Jennifer Lord to discover what France are doing to prepare for this mosquito-transmitted virus. Plus, Professor Peter Openshaw joins James to digest the latest Covid-19 inquiry and what lessons we can learn for the next pandemic. Together, they discuss why we are currently experiencing a summer wave of Covid-19. Presenter: James Gallagher Producer: Hannah Robins Assistant producer: Katie Tomsett Editor: Holly Squire

Professor Luke O'Neill, Professor of Biochemistry at the school of Immunology, Trinity College and Professor Peter Openshaw, Professor of Experimental Medicine at Imperial College London and vice-Chair or NERVTAG, a UK Department of Health committee horizon-scanning for emerging respiratory threats both joined Pat in studio to discuss the future of Covid-19.

Professor Peter Openshaw and Dr Felicity Liew discuss the use of inhaled corticosteroids in the early treatment of COVID and the involvement of the respiratory mucosa in response to viral infection. 

The government hopes to offer every adult in England the chance to book a Covid booster before the end of 2021. Booster campaigns are being brought forward across the UK, in response to worries over the Omicron variant. Today's Martha Kearney and Justin Webb put listener's questions about the booster jab and the Omicron variant of Covid-19 to the programme's panel of experts. On the panel is Professor Peter Openshaw, Immunologist at Imperial College London and a member of the UK Vaccine Network, and Professor Linda Bauld, Professor of Public Health at the University of Edinburgh, as well as Dr Sarah Jarvis, GP and clinical director of Patientaccess.com (Image credit: EPA/ ANDY RAIN)

In the next week, 12 to 15-year-olds in England will begin receiving their vaccine invitations, and booster jabs for over-50s are expected to be announced soon. Today's Justin Webb and Mishal Husain put listeners' questions about the latest stage of the Covid-19 vaccination programme to Dr Liz Whittaker, infectious disease lead at the Royal College of Paediatrics and Child Health, and Professor Peter Openshaw, immunologist at Imperial College London & member of the UK Vaccine Network. (Image: 14 year old receives his first dose of the vaccine in Dublin, Credit: Damien Storan/PA Wire)

Lord Chancellor Robert Buckland defends the government's decision to break international law by overriding the Brexit Withdrawal Agreement. He also explains the latest moves to contain coronavirus. Professor Peter Openshaw warns there is little time left to avert a major spike in Covid-19 infections.

Isabel Hardman presents the highlights from Sunday's political interviews. Today's featured interviewees are Robert Buckland, Simon Coveney, Louise Haigh and Professor Peter Openshaw.

In this edition: We hear from researchers working on a COVID-19 vaccine and with patient samples, and how students are coping in isolation. News: University Challenge win and neutrino discovery – We celebrate Imperial’s spectacular University Challenge win and discover how neutrinos may hold the key to why the universe is made up of matter rather than antimatter. On the frontlines of COVID-19 vaccine development – We speak to Dr Anna Blakney about what it’s like to work on a vaccine the whole world is waiting for. This feature is an excerpt from 'Never Lick the Spoon' – a monthly podcast from Imperial's Institute for Molecular Science and Engineering. Understanding and treating COVID-19 – We hear from Professor Peter Openshaw how thousands of samples from COVID-19 patients across the country are already providing valuable insights into the disease, including who seems to get it worse, and how the disease progresses. Isolation diaries from around the world – We hear from the producers of a video capturing snippets from Imperial students now scattered across the world.

In this edition: We hear from researchers working on a COVID-19 vaccine and with patient samples, and how students are coping in isolation. News: University Challenge win and neutrino discovery – We celebrate Imperial’s spectacular University Challenge win and discover how neutrinos may hold the key to why the universe is made up of matter rather than antimatter. On the frontlines of COVID-19 vaccine development – We speak to Dr Anna Blakney about what it’s like to work on a vaccine the whole world is waiting for. This feature is an excerpt from 'Never Lick the Spoon' – a monthly podcast from Imperial's Institute for Molecular Science and Engineering. Understanding and treating COVID-19 – We hear from Professor Peter Openshaw how thousands of samples from COVID-19 patients across the country are already providing valuable insights into the disease, including who seems to get it worse, and how the disease progresses. Isolation diaries from around the world – We hear from the producers of a video capturing snippets from Imperial students now scattered across the world.

Is the Coronavirus really a threat? I keep seeing headlines. But I don't know what to think. So I called up Professor Peter Openshaw from Imperial College London. He's a clinician, and a scientists specializing in lung immunology. In this episode, you'll learn the science. And find out what we can do to prevent it from getting into our bodies. I write about all my podcasts! Check out the full post and learn what I learned at jamesaltucher.com/podcast. Thanks so much for listening! If you like this episode, please subscribe to "The James Altucher Show" and rate and review wherever you get your podcasts: Apple Podcasts Stitcher iHeart Radio Spotify Follow me on Social Media: YouTube Twitter Facebook Linkedin Instagram ------------What do YOU think of the show? Head to JamesAltucherShow.com/listeners and fill out a short survey that will help us better tailor the podcast to our audience!Are you interested in getting direct answers from James about your question on a podcast? Go to JamesAltucherShow.com/AskAltucher and send in your questions to be answered on the air!------------Visit Notepd.com to read our idea lists & sign up to create your own!My new book, Skip the Line, is out! Make sure you get a copy wherever books are sold!Join the You Should Run for President 2.0 Facebook Group, where we discuss why you should run for President.I write about all my podcasts! Check out the full post and learn what I learned at jamesaltuchershow.com------------Thank you so much for listening! If you like this episode, please rate, review, and subscribe to "The James Altucher Show" wherever you get your podcasts: Apple PodcastsiHeart RadioSpotifyFollow me on social media:YouTubeTwitterFacebookLinkedIn

Is the Coronavirus really a threat? I keep seeing headlines. But I don’t know what to think. So I called up Professor Peter Openshaw from Imperial College London. He’s a clinician, and a scientists specializing in lung immunology. In this episode, you’ll learn the science. And find out what we can do to prevent it from getting into our bodies. I write about all my podcasts! Check out the full post and learn what I learned at jamesaltucher.com/podcast. Thanks so much for listening! If you like this episode, please subscribe to “The James Altucher Show” and rate and review wherever you get your podcasts: Apple Podcasts Stitcher iHeart Radio Spotify   Follow me on Social Media: YouTube Twitter Facebook Linkedin Instagram See omnystudio.com/listener for privacy information.

MRC Science Content Editor Isabel Baker interviews Professor Peter Openshaw, Professor of Experimental Medicine at Imperial College London and President of the British Society for Immunology.